← Cases
South KoreaHealthcare and life sciences2026 – ongoing

DTnCRO

AI agent-based support system for non-clinical test work

DTnCRO's AI agent system for test work reported automation gains of 40% and 38% in two centers

In progressCompany's own claim

Problem

DTnCRO is a contract research organization. Its efficacy, safety and analysis centers spend much staff time on literature review, protocols, reports and quality checks.

Approach

The company's AI Planning Office built an AI agent-based system on data from its testing process. It supports literature review, test design, protocols and reports, QC checks for regulatory non-compliance, and automatic recalculation of test data. DTnCRO also planned a pathology slide reading assistant and an extension to clinical trials.

Results

40%AI automation improvement rate at the efficacy evaluation center, per the companyCompany's own claim[1]
38%AI automation improvement rate at the analysis center, per the companyCompany's own claim[1]

Takeaway

The rates came from the company and the article did not say how they were measured. Work on pathology and clinical trials was still planned.

Categories

Innovation type
Process innovation
Evidence
Company's own claim

Sources

Source summaries

[1]Electronic Times11 May 2026

Award coverage of DTnCRO. It describes an AI agent-based test-operations system and gives automation improvement rates of 40% for efficacy, the 30% range for safety and 38% for analysis. A pathology reading assistant and clinical-trial use were still planned.

Full details are in the original sources.

Added 1 Nov 2026 · Updated 1 Nov 2026
Open case page ↗